Asia Pacific Hematuria Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Treatment (Drugs, Therapies, and Others), Indication (Urinary Tract Infections, Kidney Stones, Urethritis, Blood Cancer, Bladder Stones, Prostate Cancer, Cystitis, Trauma, Vigorous Exercise, Polycystic Kidney Disease, Endometriosis, and Menstruation), Type (Macroscopic Hematuria, Microscopic Hematuria, Idiopathic Hematuria, and Jogger’s Hematuria), End User (Hospitals, Clinics, and Ambulatory Surgical Centers, and Others)

TIPRE00026249 | Pages: 181 | Pharmaceuticals | Dec 2021 | Type: Regional | Status: Published

Market Introduction

Hematuria is a medical condition where presence of blood is found in the urine. Generally, urine does not contain RBC and hence this can result in serious issue that may also cause kidney stones, urinary tract infection and other inherited diseases.

Moreover, the high prevalence hematuria associated indications is expected to bolster the market growth during the forecast period. However, undiagnosed cases of associated indications limit the growth of the Asia Pacific hematuria treatment market.

The COVID-19 outbreak has severely affected the tourism industry and imposed supply chain disruptions; moreover, low-income countries face additional challenges due to the shortage of healthcare infrastructure. Restrictive measures have been put forth in South Korea, Malaysia, Singapore, the Philippines, and India to prevent disease transmission. All these factors impacted moderately on hematuria treatment market for a short period of time due to restrictions on the supply chain as well as limited manufacturing capabilities. Renal involvement in COVID -19 patients may have a wide range of manifestations, including hematuria, proteinuria, pyuria, and acute kidney injury (AKI). Proteinuria and hematuria have been reported to have a higher prevalence of COVID 19 than AKI. On the other hand, AKI is currently a disturbing sign of hospitalized COVID 19 patients and a major risk factor for death. Therefore, the hematuria treatment market is positively affected by COVID19.

Market Overview and Dynamics

The Asia Pacific hematuria treatment market is projected to reach US$ 257.6 million by 2028 from US$ 211.0 million in 2021; it is anticipated to grow at a CAGR of 2.9% from 2021 to 2028. Healthcare expenditure has considerably increased due to the rising prevalence of chronic indications. The governments of various economies are investing substantially in improving the healthcare infrastructure. Moreover, patients in developed economies are becoming aware of the possible treatments and availability of reimbursement for the hematuria treatment. Hematuria is among the initial indications of chronic diseases such as blood cancer, bladder cancer, and kidney cancer. These diseases are covered under various health insurance policies that help the easy treatment of the patients and reduce the financial burden for healthcare. Thus, improving healthcare expenditure and awareness among the patients about the treatment is driving the Asia Pacific hematuria treatment market.

Key Market Segments

In terms of type, the macroscopic hematuria segment accounted for the largest share of the Asia Pacific hematuria treatment market in 2020. In terms of treatment, the drugs segment accounted for the largest share of the Asia Pacific hematuria treatment market in 2020. In terms of indication, the urinary tract infection segment accounted for the largest share of the Asia Pacific hematuria treatment market in 2020. In terms of end user, the hospitals segment accounted for the largest share of the Asia Pacific hematuria treatment market in 2020.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the hematuria treatment market in Asia Pacific are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are AstraZeneca, Bristol-Myers Squibb Company, F. HOFFMANN-LA ROCHE LTD., GlaxoSmithKline plc., Janssen Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd, and Boehringer Ingelheim International GmbH.

Reasons to Buy Report

  • To understand the Asia Pacific hematuria treatment market landscape and identify market segments that are likely to guarantee a strong return
  • To comprehend the ever-changing market landscape and stay ahead in competition
  • To efficiently plan merger and acquisition, and partnership deals in the Asia Pacific hematuria treatment market by identifying segments with the most promising probable sales
  • To make knowledgeable business decisions from perceptive and comprehensive analysis of the market performance of various segments
  • To obtain market revenue forecast of the Asia Pacific hematuria treatment market based on various segments for the period 2021–2028

ASIA PACIFIC HEMATURIA TREATMENT MARKET SEGMENTATION

By Treatment

  • Drugs
  • Therapies
  • Others

By Indication

  • Urinary Tract Infections
  • Kidney Stones
  • Urethritis
  • Blood Cancer
  • Bladder Stones
  • Prostate Cancer
  • Cystitis
  • Trauma
  • Vigorous Exercise
  • Polycystic Kidney Disease
  • Endometriosis
  • Menstruation

By Type

  • Macroscopic Hematuria
  • Microscopic Hematuria
  • Idiopathic Hematuria
  • Jogger’s Hematuria

By End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers (ASC's)
  • Others

By Country

  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific

Companies Mentioned

  1. AstraZeneca
  2. Bristol-Myers Squibb Company
  3. F. HOFFMANN-LA ROCHE LTD.
  4. GlaxoSmithKline plc.
  5. Janssen Pharmaceuticals
  6. Merck & Co., Inc.
  7. Novartis AG
  8. Pfizer Inc.
  9. Sun Pharmaceutical Industries Ltd
  10. Boehringer Ingelheim International GmbH

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Hematuria Treatment Market – By Treatment

1.3.2        Asia Pacific Hematuria Treatment Market – By Indication

1.3.3        Asia Pacific Hematuria Treatment Market – By Type

1.3.4        Asia Pacific Hematuria Treatment Market – By End User

1.3.5        Asia Pacific Hematuria Treatment Market – By Country

2.           Asia Pacific Hematuria Treatment Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Hematuria Treatment Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Asia Pacific – PEST Analysis

4.3         Experts Opinion

5.           Hematuria Treatment Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        High Prevalence of Hematuria-Associated Indications

5.1.2        Increasing Awareness About Treatment Options and Improving Healthcare Expenditure

5.2         Market Restraints

5.2.1        Undiagnosed Cases of Associated Indications

5.3         Market Opportunities

5.3.1        Increasing Opportunities for Related Treatments

5.4         Future Trends

5.4.1        Rise in Preference for Advanced Therapies

5.5         Impact Analysis

6.           Hematuria Treatment Market – Asia Pacific Analysis

6.1         Asia Pacific Hematuria Treatment Market Revenue Forecast and Analysis

7.           Hematuria Treatment Market Revenue and Forecast To 2028 – By Treatment

7.1         Overview

7.2         Asia Pacific Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)

7.3         Drugs

7.3.1        Overview

7.3.2        Drugs: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

7.4         Therapies

7.4.1        Overview

7.4.2        Therapies: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

7.5         Others

7.5.1        Overview

7.5.2        Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.           Hematuria Treatment Market Revenue and Forecast To 2028 – By Indication

8.1         Overview

8.2         Asia Pacific Hematuria Treatment Market Share by Indication 2020 & 2028 (%)

8.3         Kidney Stones

8.3.1        Overview

8.3.2        Kidney Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Urinary Tract Infections (UTI)

8.4.1        Overview

8.4.2        Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.5         Urethritis

8.5.1        Overview

8.5.2        Urethritis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.6         Blood Cancer

8.6.1        Overview

8.6.2        Blood Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.7         Bladder Stones

8.7.1        Overview

8.7.2        Bladder Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.8         Prostate Cancer

8.8.1        Overview

8.8.2        Prostate Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.9         Cystitis

8.9.1        Overview

8.9.2        Cystitis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.10      Trauma

8.10.1     Overview

8.10.2     Trauma: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.11      Vigorous Exercise

8.11.1     Overview

8.11.2     Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.12      Polycystic Kidney Disease

8.12.1     Overview

8.12.2     Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.13      Endometriosis

8.13.1     Overview

8.13.2     Endometriosis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.14      Menstruation

8.14.1     Overview

8.14.2     Menstruation: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

9.           Hematuria Treatment Market Revenue and Forecast To 2028 – By Type

9.1         Overview

9.2         Asia Pacific Hematuria Treatment Market, By Type 2020 & 2028 (%)

9.3         Macroscopic Hematuria

9.3.1        Overview

9.3.2        Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

9.4         Microscopic Hematuria

9.4.1        Overview

9.4.2        Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

9.5         Idiopathic Hematuria

9.5.1        Overview

9.5.2        Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

9.6         Jogger’s Hematuria

9.6.1        Overview

9.6.2        Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

10.        Hematuria Treatment Market Revenue and Forecast To 2028 – By End User

10.1      Overview

10.2      Asia Pacific Hematuria Treatment Market Share by End User 2020 & 2028 (%)

10.3      Hospitals

10.3.1     Overview

10.3.2     Hospitals: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

10.4      Clinics

10.4.1     Overview

10.4.2     Clinics: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

10.5      Ambulatory Surgical Centers (ASC’s)

10.5.1     Overview

10.5.2     Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

10.6      Others

10.6.1     Overview

10.6.2     Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

11.        Asia Pacific Hematuria Treatment Market – Geographic Analysis

11.1      Asia Pacific: Hematuria Treatment Market

11.1.1     Overview

11.1.2     Asia Pacific: Hematuria Treatment Market - Revenue and Forecast to 2028 (US$ Million)

11.1.3     Asia Pacific: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

11.1.4     Asia Pacific: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)

11.1.5     Asia Pacific: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)

11.1.6     Asia Pacific: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)

11.1.7     Asia Pacific: Hematuria Treatment Market, by Country, 2021 & 2028 (%)

11.1.7.1       China: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.1       China: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.2       China: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

11.1.7.1.3       China: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)

11.1.7.1.4       China: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)

11.1.7.1.5       China: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)

11.1.7.2       Japan: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.1       Japan: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.2       Japan: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

11.1.7.2.3       Japan: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)

11.1.7.2.4       Japan: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)

11.1.7.2.5       Japan: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)

11.1.7.3       India: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.1       India: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.2       India: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

11.1.7.3.3       India: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)

11.1.7.3.4       India: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)

11.1.7.3.5       India: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)

11.1.7.4       South Korea: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.4.1       South Korea: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.4.2       South Korea: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

11.1.7.4.3       South Korea: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)

11.1.7.4.4       South Korea: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)

11.1.7.4.5       South Korea: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)

11.1.7.5       Australia: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.5.1       Australia: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.5.2       Australia: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

11.1.7.5.3       Australia: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)

11.1.7.5.4       Australia: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)

11.1.7.5.5       Australia: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)

11.1.7.6       Rest of Asia Pacific: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.6.1       Rest of Asia Pacific: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.1.7.6.2       Rest of Asia Pacific: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

11.1.7.6.3       Rest of Asia Pacific: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)

11.1.7.6.4       Rest of Asia Pacific: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)

11.1.7.6.5       Rest of Asia Pacific: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)

12.        Impact Of COVID-19 Pandemic on Hematuria Treatment Market

12.1      Asia Pacific: Impact Assessment of COVID-19 Pandemic

13.        Hematuria Treatment Market–Industry Landscape

13.1      Overview

13.2      Growth Strategies Done by the Companies in the Market, (%)

13.3      Organic Developments

13.3.1     Overview

13.4      Inorganic Developments

13.4.1     Overview

14.        Company Profiles

14.1      AstraZeneca

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      Bristol-Myers Squibb Company

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      F. HOFFMANN-LA ROCHE LTD.

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      GlaxoSmithKline Plc

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Janssen Pharmaceuticals

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      Merck & Co., Inc.

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7      Novartis AG

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8      Pfizer Inc.

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9      Sun Pharmaceutical Industries Ltd

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

14.10   Boehringer Ingelheim International GmbH

14.10.1  Key Facts

14.10.2  Business Description

14.10.3  Products and Services

14.10.4  Financial Overview

14.10.5  SWOT Analysis

14.10.6  Key Developments

15.        Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             Asia Pacific: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Asia Pacific: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)

Table 3.             Asia Pacific: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Asia Pacific: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 5.             China: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 6.             China: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)

Table 7.             China: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 8.             China: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Japan: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Japan: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)

Table 11.          Japan: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Japan: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13.          India: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 14.          India: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)

Table 15.          India: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 16.          India: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 17.          South Korea: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 18.          South Korea: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)

Table 19.          South Korea: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 20.          South Korea: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 21.          Australia: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Australia: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)

Table 23.          Australia: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 24.          Australia: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 25.          Rest of Asia Pacific: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 26.          Rest of Asia Pacific: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)

Table 27.          Rest of Asia Pacific: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 28.          Rest of Asia Pacific: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 29.          Organic Developments Done by Companies

Table 30.          Inorganic Developments Done by Companies

Table 31.          Glossary of Terms, Hematuria Treatment Market

 


LIST OF FIGURES

Figure 1.           Hematuria Treatment Market Segmentation

Figure 2.           Asia Pacific Hematuria Treatment Market Overview

Figure 3.           Macroscopic Hematuria Segment Held the Largest Share of the Type Segment in Hematuria Treatment Market

Figure 4.           India to Show Significant Growth During Forecast Period

Figure 5.           Asia Pacific Hematuria Treatment Market, Industry Landscape

Figure 6.           Asia Pacific PEST Analysis

Figure 7.           Hematuria Treatment Market Impact Analysis of Drivers and Restraints

Figure 8.           Asia Pacific Hematuria Treatment Market – Revenue Forecast and Analysis – 2020- 2028

Figure 9.           Asia Pacific Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)

Figure 10.        Drugs: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 11.        Therapies: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 12.        Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 13.        Asia Pacific Hematuria Treatment Market Share by Indication 2020 & 2028 (%)

Figure 14.        Kidney Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 15.        Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 16.        Urethritis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 17.        Blood Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 18.        Bladder Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 19.        Prostate Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 20.        Cystitis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 21.        Trauma: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 22.        Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 23.        Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 24.        Endometriosis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 25.        Menstruation: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 26.        Asia Pacific Hematuria Treatment Market, by Type 2020 & 2028 (%)

Figure 27.        Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 28.        Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 29.        Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 30.        Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 31.        Asia Pacific Hematuria Treatment Market Share by End User 2020 & 2028 (%)

Figure 32.        Hospitals: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 33.        Clinics: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 34.        Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 35.        Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 36.        Asia Pacific: Hematuria Treatment Market, by Key Country – Revenue (2021) (US$ Million)

Figure 37.        Asia Pacific: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Million)

Figure 38.        Asia Pacific: Hematuria Treatment Market, by Country, 2021 & 2028 (%)

Figure 39.        China: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40.        Japan: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41.        India: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 42.        South Korea: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43.        Australia: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 44.        Rest of Asia Pacific: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 45.        Impact Of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 46.          Growth Strategies Done by the Companies in the Market, (%)
  1. AstraZeneca
  2. Bristol-Myers Squibb Company
  3. F. HOFFMANN-LA ROCHE LTD.
  4. GlaxoSmithKline plc.
  5. Janssen Pharmaceuticals
  6. Merck & Co., Inc.
  7. Novartis AG
  8. Pfizer Inc.
  9. Sun Pharmaceutical Industries Ltd
  10. Boehringer Ingelheim International GmbH
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific hematuria treatment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific hematuria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000